- Home
- BWLP vs CNTA Comparison
BWLP vs CNTA Comparison
Compare BWLP & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- CNTA
- Stock Information
- Founded
- BWLP 1935
- CNTA 2020
- Country
- BWLP Singapore
- CNTA United Kingdom
- Employees
- BWLP N/A
- CNTA N/A
- Industry
- BWLP Marine Transportation
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- BWLP Consumer Discretionary
- CNTA Health Care
- Exchange
- BWLP Nasdaq
- CNTA Nasdaq
- Market Cap
- BWLP 1.9B
- CNTA 2.2B
- IPO Year
- BWLP N/A
- CNTA 2021
- Fundamental
- Price
- BWLP $13.00
- CNTA $16.00
- Analyst Decision
- BWLP
- CNTA Strong Buy
- Analyst Count
- BWLP 0
- CNTA 7
- Target Price
- BWLP N/A
- CNTA $23.71
- AVG Volume (30 Days)
- BWLP 326.1K
- CNTA 463.7K
- Earning Date
- BWLP 01-01-0001
- CNTA 11-12-2024
- Dividend Yield
- BWLP 25.25%
- CNTA N/A
- EPS Growth
- BWLP 43.64
- CNTA N/A
- EPS
- BWLP 3.64
- CNTA N/A
- Revenue
- BWLP $3,510,244,000.00
- CNTA $6,853,000.00
- Revenue This Year
- BWLP N/A
- CNTA N/A
- Revenue Next Year
- BWLP $1.46
- CNTA N/A
- P/E Ratio
- BWLP $3.60
- CNTA N/A
- Revenue Growth
- BWLP 57.96
- CNTA N/A
- 52 Week Low
- BWLP $10.32
- CNTA $5.58
- 52 Week High
- BWLP $22.31
- CNTA $18.74
- Technical
- Relative Strength Index (RSI)
- BWLP 44.10
- CNTA 49.07
- Support Level
- BWLP $12.48
- CNTA $15.15
- Resistance Level
- BWLP $13.44
- CNTA $18.74
- Average True Range (ATR)
- BWLP 0.28
- CNTA 0.88
- MACD
- BWLP 0.09
- CNTA 0.10
- Stochastic Oscillator
- BWLP 52.26
- CNTA 35.68
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.